MEDRIXX

How We Vet

The MEDRIXX
Standard.

Regenerative and cosmetic biologics have moved faster than regulation, and marketing has too often outrun the evidence. Before MEDRIXX represents a manufacturing partner to a practice, that partner has to clear a standard — not a sales pitch.

01

Sourcing & Donor Eligibility

Represented tissue-based partners must document exactly where material comes from and how each donor was cleared, before we bring a product to a practice.

Tissue accepted only from full-term, live-birth C-section donors
Sourced exclusively through AABB-accredited U.S. cord banks
Donors screened across a full infectious-disease panel — HIV, Hepatitis B & C, HTLV, syphilis, CMV, Zika, West Nile virus, and Chagas disease
Documentation maintained in line with FDA Section 361 and 21 CFR Part 1271

02

Manufacturing & Environment

We favor partners who treat manufacturing as engineering, not craft — controlled, documented, and repeatable from one lot to the next.

Manufactured exclusively in FDA-registered U.S. facilities
Produced in classified cleanroom environments with validated air, pressure, and particulate monitoring
Protocol-driven production designed for batch-to-batch consistency
Full chain-of-custody traceability from source tissue to finished lot

03

Testing & Release

A product doesn't ship on a partner's word. Independent, third-party data has to back every claim before it reaches a practice.

Every batch tested by an independent lab for USP <71> sterility and USP <85> endotoxin levels
Exosome-based products characterized by independent particle (DLS) and proteomic (mass-spectrometry) analysis
Results reviewed against applicable FDA release criteria before a lot ships
Lot-level certificates of analysis available to represented practices on request

04

Education & Support

Documentation only helps if a practice can actually use it. We translate it, and we stay reachable after the first order.

Plain-language technical briefings, not marketing decks
Practice-level protocol and workflow support
Direct, independent representation — not a call center
Ongoing access to regulatory and documentation updates

Private Consultation

Let’s talk
practice.

Tell us what your practice is exploring. A MEDRIXX representative will follow up with relevant professional information.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.